B7-H3 in Cancer – Beyond Immune Regulation

Trends in Cancer - United States
doi 10.1016/j.trecan.2018.03.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Glycoprotein B7-H3 Overexpression and Aberrant Glycosylation in Oral Cancer and Immune Response

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

The Third Group of the B7-Cd28 Immune Checkpoint Family: HHLA2, TMIGD2, B7x, and B7-H3

Immunological Reviews
AllergyImmunology
2017English

Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging

Cancer Research
Cancer ResearchOncology
2015English

Aberrant Expression of B7-H3 in Gastric Adenocarcinoma Promotes Cancer Cell Metastasis

Oncology Reports
MedicineCancer ResearchOncology
2014English

B7-H3, a Checkpoint Molecule, as a Target for Cancer Immunotherapy

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

The Contrasting Role of B7-H3

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

B7-H3 as a Promising Target for Cytotoxicity T Cell in Human Cancer Therapy

Oncotarget
Oncology
2016English

Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer

Cancer immunology research
Cancer ResearchImmunology
2015English

B7-H3 Promotes Aerobic Glycolysis and Chemoresistance in Colorectal Cancer Cells by Regulating HK2

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy